AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 166 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $94,905,000 | -44.2% | 3,720 | -56.1% | 0.00% | – |
| Q2 2014 | $169,948,000 | -91.0% | 8,472 | -90.7% | 0.00% | -100.0% |
| Q4 2013 | $1,889,040,000 | +670.4% | 91,082 | +576.1% | 0.00% | – |
| Q3 2013 | $245,190,000 | -51.5% | 13,472 | -55.7% | 0.00% | – |
| Q2 2013 | $505,598,000 | – | 30,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,854,631 | $97,384,000 | 7.25% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,267,382 | $125,724,000 | 5.06% |
| Healthcare Value Capital, LLC | 229,481 | $4,603,000 | 3.86% |
| Tamarack Capital Management, LLC | 943,526 | $18,352,000 | 3.75% |
| KING INVESTMENT ADVISORS INC/TX | 248,065 | $4,976,000 | 2.12% |
| TAMRO Capital Partners LLC | 1,889,738 | $37,908,000 | 1.92% |
| Healthcare Value Capital, LLC | 100,000 | $2,006,000 | 1.68% |
| Artal Group S.A. | 2,015,000 | $40,421,000 | 1.63% |
| Tiger Legatus Capital Management, LLC | 150,000 | $3,009,000 | 1.14% |
| DAVIDE LEONE & PARTNERS INVESTMENT Co LLP | 272,000 | $5,456,000 | 1.12% |